Vitenskapelig artikkel

• Hassan Osman Alhassan Elsaid; Jessica Furriol Palmer; Øystein Solberg Eikrem et al. (2026). Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. (ekstern lenke)
• Camilla Tøndel; Uma Ramaswami; Kristin Moberg Aakre et al. (2009). Monitoring renal Function in Fabry children: comparisons of measured and creatinine-based estimated Glomerular Filtration Rate. (ekstern lenke)
• Elisabeth Berge Svendsen; Rolf E.F. Christiansen; Einar Svarstad et al. (2008). En kvinne med kronisk nyresvikt, progredierende hudforkalkninger og sepsis. (ekstern lenke)
• Rannveig Skrunes; Einar Svarstad; Kristin Kampevold Larsen et al. (2016). Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients. (ekstern lenke)
• Einar Svarstad; Bjarne Magnus Iversen; Leif Bostad (2004). Bedside stereomicroscopy of renal biopsies may lead to a rapid diagnosis of Fabry's disease. (ekstern lenke)
• Erlend Hodneland; Eirik Keilegavlen; Erik Andreas Hanson et al. (2018). In vivo detection of chronic kidney disease using tissue deformation fields from dynamic MR imaging.. (ekstern lenke)
• Agnes B Fogo; Leif Bostad; Einar Svarstad et al. (2010). Scoring system for renal pathology in Fabry disease: Report of the International Study Group of Fabry Nephropathy (ISGFN). (ekstern lenke)
• Francis F. Fredrick; Paschal J. Ruggajo; Gopal Basu et al. (2015). Global collaboration bears fruit: Tanzania report. (ekstern lenke)
• Camilla Tøndel; Takahiro Kanai; Kristin Kampevold Larsen et al. (2015). Foot process effacement is an early marker of nephropathy in young classic fabry patients without albuminuria. (ekstern lenke)
• Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter et al. (2014). Familial clustering of ESRD in the Norwegian population. (ekstern lenke)
• Camilla Tøndel; Leif Bostad; Kristin Kampevold Larsen et al. (2013). Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease. (ekstern lenke)
• Ida Viken Stalund; Gro Nygard Riise; Friedemann Leh et al. (2021). Case Report: Polyvinylpyrrolidone deposition disease from repeated injection of opioid substitution drugs: Report of a case with a fatal outcome. (ekstern lenke)
• Jan Inge Sørheim; Eystein Sverre Husebye; Bjørn Gunnar Nedrebø et al. (2010). Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. (ekstern lenke)
• Rune Oskar Bjørneklett; Bjørn Egil Vikse; Einar Svarstad et al. (2007). Long-term risk of cancer in membranous nephropathy patients. (ekstern lenke)
• Lene Frøyen Sandvik; Kathrine Skarstein; Lisbeth Sviland et al. (2013). CD11c+ dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients. (ekstern lenke)
• Karsten Midtvedt; Per Fauchald; Stein Bergan et al. (2003). C2 monitoring in maintenance renal transplant recipients: is it worthwhile?. (ekstern lenke)
• RE Christiansen; Lisbet Sviland; Irene Sekse et al. (2009). Nephrogenic systemic fibrosis and use of MR contrast media. (ekstern lenke)
• David G. Warnock; Alberto Ortiz; Michael Mauer et al. (2012). Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation. (ekstern lenke)
• Julian F Guest; Trond Jenssen; Gunnar Houge et al. (2010). Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion. (ekstern lenke)
• Einar Svarstad; Sabine Maria Leh; Rannveig Skrunes et al. (2017). Bedside stereomicroscopy of Fabry kidney biopsies: An easily available method for diagnosis and assessment of sphingolipid deposits. (ekstern lenke)
• Øystein Solberg Eikrem; Rannveig Skrunes; Camilla Tøndel et al. (2017). Pathomechanisms of renal Fabry disease. (ekstern lenke)
• Camilla Tøndel; Uma Ramaswami; Kristin Moberg Aakre et al. (2010). Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate. (ekstern lenke)
• Einar Svarstad; Hans-Peter Marti (2020). The changing landscape of Fabry disease. (ekstern lenke)
• Ann-Helen Kristoffersen; Tormod Karlsen Bjånes; Stina Jordal et al. (2016). Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure. (ekstern lenke)
• Kristin Aakre; Geir Thue; Einar Svarstad et al. (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. (ekstern lenke)
• Kristin Aakre; Thomas Helge Røraas; Per Hyltoft Petersen et al. (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. (ekstern lenke)
• Gabor E. Linthorst; Allessandro Burlina; Franco Cecchi et al. (2012). Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage. (ekstern lenke)
• Camilla Tøndel; Bjørn Egil Vikse; Leif Bostad et al. (2012). Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. (ekstern lenke)
• Derralynn A. Hughes; Patricio Aguiar; Patrick B Deegan et al. (2020). Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: Findings from the opinion-based PREDICT-FD modified Delphi consensus initiative. (ekstern lenke)
• Hassan Osman Alhassan Elsaid; Mariell Lossius Rivedal; Eleni Skandalou et al. (2023). Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla ^−/− zebrafish model of Fabry disease. (ekstern lenke)
• Kristin M. Aakre; Camilla Tøndel; Atle Brun et al. (2009). The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function. (ekstern lenke)
• Nicolas Delaleu; Hans Peter Marti; Philipp Strauss et al. (2023). Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing. (ekstern lenke)
• Linda van der Tol; David Cassiman; Gunnar Houge et al. (2014). Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up. (ekstern lenke)
• Paschal Joseph Ruggajo; Sabine Maria Leh; Einar Svarstad et al. (2018). Low birth weight associates with glomerular area in young male IgA nephropathy patients. (ekstern lenke)
• Camilla Tøndel; Bjørn Johan Bolann; Cathrin Lytomt Salvador et al. (2016). Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling times. (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2020). Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss. (ekstern lenke)
• Hassan Osman Alhassan Elsaid; Jessica Furriol; Maria Blomqvist et al. (2022). Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype. (ekstern lenke)
• Gudrun Norby; Geir Mjøen; Rune Bjørneklett et al. (2017). Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. (ekstern lenke)
• Thea Tislevoll Eide; Karl Ove Hufthammer; Atle Brun et al. (2021). Accuracy of single intravenous access iohexol GFR in children is hampered by marker contamination. (ekstern lenke)
• Einar Svarstad; Leif Bostad; Øyvind Kaarbøe et al. (2005). Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. (ekstern lenke)
• Michael Mauer; Emily Glynn; Einar Svarstad et al. (2014). Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease. (ekstern lenke)
• Francis F. Furia; Jacqueline Shoo; Paschal Joseph Ruggajo et al. (2019). Developing nephrology services in low income countries: A case of Tanzania. (ekstern lenke)
• Einar Svarstad; Lasse Urheim; Bjarne Magnus Iversen (2005). Critical renal artery stenoses may cause a spectrum of cardiorenal failure and associated thromboembolic events. (ekstern lenke)
• Linda van der Tol; Einar Svarstad; Alberto Ortiz et al. (2014). Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis. (ekstern lenke)
• Miriam Kristine Sandvik; Stein Hallan; Einar Svarstad et al. (2013). Preeclampsia and prevalence of microalbuminuria 10 years later. (ekstern lenke)
• Thomas Knoop; Ann Merethe Vågane; Bjørn Egil Vikse et al. (2015). Addition of eGFR and age improves the prognostic absolute renal risk-model in 1,134 norwegian patients with IgA nephropathy. (ekstern lenke)
• Hassan Osman Alhassan Elsaid; Håkon Tjeldnes; Mariell Lossius Rivedal et al. (2022). Gene Expression Analysis in gla-Mutant Zebrafish Reveals Enhanced Ca²⁺ Signaling Similar to Fabry Disease. (ekstern lenke)
• Miriam Kristine Sandvik; Elisabeth Leirgul; Ottar Nygård et al. (2013). Preeclampsia in healthy women and endothelial dysfunction 10 years later. (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2016). One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease. (ekstern lenke)
• Camilla Tøndel; Leif Bostad; Asle Hirth et al. (2008). Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. (ekstern lenke)
• Rafael Alexander Leiva; Einar Svarstad; Bjarne Magnus Iversen (2001). Akutt dialysebehandling ved Haukeland Sykehus i 1999. (ekstern lenke)
• Einar Svarstad; Ole Langeland Myking; Jarle Ofstad et al. (2001). Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure. Role of upright body position. (ekstern lenke)
• Paschal Joseph Ruggajo; Einar Svarstad; Sabine Maria Leh et al. (2016). Low birth weight and risk of progression to end stage renal disease in IgA nephropathy - A retrospective registry-based cohort study. (ekstern lenke)
• David Moreno-Martinez; Patricio Aguiar; Christiane Auray-Blais et al. (2021). Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus. (ekstern lenke)
• Friedemann Leh; Ida Viken Stalund; Tormod Karlsen Bjånes et al. (2021). Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case series. (ekstern lenke)
• Eli Nina Eikefjord; Erling Andersen; Erlend Hodneland et al. (2015). Use of 3D DCE-MRI for the estimation of renal perfusion and glomerular filtration rate: An intrasubject comparison of FLASH and KWIC with a comprehensive framework for evaluation. (ekstern lenke)
• Federica Rossi; Einar Svarstad; Hassan Elsaid et al. (2021). Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease. (ekstern lenke)
• Einar Svarstad; Dieter Hultstrøm; Dag Jensen et al. (2001). Akutt nyresvikt, nyrearteriestenose og angiotensinkonvertase (ACE)-hemmer. (ekstern lenke)
• Einar Svarstad; Eva Gerdts; Per Omvik et al. (2001). Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. (ekstern lenke)
• David Smerkous; Michael Mauer; Camilla Tøndel et al. (2023). Development of an automated estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases.. (ekstern lenke)
• Rannveig Skrunes; Camilla Tøndel; Sabine Maria Leh et al. (2017). Long-term dose-dependent agalsidase effects on kidney histology in fabry disease. (ekstern lenke)
• Marieke Biegstraaten; R Arngrímsson; F Barbey et al. (2015). Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: The European Fabry Working Group consensus document. (ekstern lenke)
• Ida Viken Stalund; Heidi Lønne Grønseth; Finn P. Reinholt et al. (2022). Chronic Kidney Disease from Polyvinylpyrrolidone Deposition in Persons with Intravenous Drug Use. (ekstern lenke)
• Einar Svarstad; Ole Langeland Myking; Jarle Ofstad et al. (2002). Effect of light excercise on renal hemodynamics in patients with hypertension and chronic renal disease. (ekstern lenke)
• Eli Bjøvad Eikefjord; Erling Andersen; Erlend Hodneland et al. (2016). Dynamic contrast-enhanced MRI measurement of renal function in healthy participants. (ekstern lenke)
• Behzad Najafian; Aurelio Silvestroni; Alexey Sokolovskiy et al. (2022). A novel unbiased method reveals progressive podocyte globotriaosylceramide accumulation and loss with age in females with Fabry disease. (ekstern lenke)
• Camilla Tøndel; Cathrin Lytomt Salvador; Karl Ove Hufthammer et al. (2017). Iohexol plasma clearance in children: validation of multiple formulas and single-point sampling times. (ekstern lenke)
• Behzad Najafian; Einar Svarstad; Leif Bostad et al. (2011). Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. (ekstern lenke)
• Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter et al. (2016). End stage renal disease predicts increased risk of death in first degree relatives in the Norwegian population. (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2013). Mortality in patients with IgA nephropathy. (ekstern lenke)
• Paschal Joseph Ruggajo; Rannveig Skrunes; Einar Svarstad et al. (2016). Familial Factors, Low Birth Weight, and Development of ESRD: A Nationwide Registry Study. (ekstern lenke)
• Eli Bjøvad Eikefjord; Erling Andersen; Erlend Hodneland et al. (2016). Quantifcation of single-kidney function and volume in living kidney donors using dynamic contrast-enhanced MRI. (ekstern lenke)
• Øyvind Skadberg; Sverre Sandberg; Thomas Røraas et al. (2016). The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. (ekstern lenke)

Konferanseforedrag

• Einar Svarstad (2001). Akutt nyresvikt, epidemiologi og nyreerstattende behandling. (ekstern lenke)
• Einar Svarstad (2001). ACE-hemmere og nyresvikt. (ekstern lenke)
• Einar Svarstad (2001). Akutt nyresvikt (forekomst, diagnostikk, dialyseindikasjon). (ekstern lenke)
• Einar Svarstad (2001). Ultralyd og Doppler av nyrer. (ekstern lenke)
• Olav H. Haugen; Camilla Tøndel; Einar Svarstad (2009). Corneal changes in Fabry's disease. (ekstern lenke)
• Philipp Strauss; Øystein Solberg Eikrem; Camilla Tøndel et al. (2019). Fabry Nephropathy: First mRNA-seq Findings from Kidney Biopsies Before and After Enzyme Replacement Therapy. (ekstern lenke)
• Camilla Tøndel; Idunn Riisnes; Sabine Leh et al. (2021). Cleared Podocytes and Normal Kidney Function in Classical Fabry Males 15 Years After Start of Enzyme Replacement Therapy at Young Age. (ekstern lenke)
• Camilla Tøndel; Leif Bostad; Einar Svarstad (2010). 5 YEARS FOLLOW-UP RENAL BIOPSIES IN PAEDIATRIC AND ADULT FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY. (ekstern lenke)
• Ida Viken Stalund; Heidi Grønseth; Finn P. Reinholt et al. (2019). Renal Polyvinylpyrrolidone Deposition from Illicit Drug Use is Associated with Tubulointerstitial Nephropathy. (ekstern lenke)
• Ida Viken Stalund; Friedemann Leh; Tormod Karlsen Bjånes et al. (2020). Polyvinylpyrrolidon (PVP) lagringssykdom hos ruspasienter – en case-serie. (ekstern lenke)
• Camilla Tøndel; Einar Svarstad (2013). Podocytes: Therapeutic Target in Fabry Disease?. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Rolf E.F. Christiansen; Lisbet Sviland; Ingegjerd Sekse et al. (2009). Nefrogen systemisk fibrose ved bruk av MR-kontrastmiddel. (ekstern lenke)
• Kristin Sæle; Hogne Sønnesyn; Einar Svarstad et al. (2009). Kognitiv svikt ved terminal nyresykdom. (ekstern lenke)
• Björn Öqvist; Barry M. Brenner; João Paulo Oliveira et al. (2009). Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations. (ekstern lenke)
• Federica Rossi; Vincenzo L'Imperio; Hans-Peter Marti et al. (2020). Proteomics for the study of new biomarkers in Fabry disease: State of the art. (ekstern lenke)
• Frank Gerrit Zöllner; Einar Svarstad; Antonella Zanna Munthe-Kaas et al. (2012). Assessment of Kidney Volumes From MRI: Acquisition and Segmentation Techniques. (ekstern lenke)
• Behzad Najafian; Michael Mauer; RJ Hopkin et al. (2012). Renal complications of Fabry disease in children. (ekstern lenke)

Konferanseposter

• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2015). Podocyte Globotriaosylceramide (GL3) Accumulation in Fabry Disease Is Influenced by Age and Genotype. (ekstern lenke)
• Rannveig Skrunes; Camilla Tøndel; Kristin Kampevold Larsen et al. (2015). LONG-TERM ENZYME REPLACEMENT THERAPY (ERT) BENEFITS THE GLOMERULI MORE THAN THE VASCULATURE IN YOUNGER FABRY NEPHROPATHY. (ekstern lenke)
• Rannveig Skrunes; Einar Svarstad; Kristin Kampevold Larsen et al. (2015). DIFFERENTIAL KIDNEY EFFECTS OF HIGH AND LOW ENZYME DOSE IN MALE SIBLINGS TREATED FOR 13 YEARS. (ekstern lenke)
• Ole Langeland Myking; Einar Svarstad; Bjarne Magnus Iversen (2001). Vitamin D Resistant Acid Phosphatase 5B and Osteocalcin in Bone Metabolism in Patients (PTS) Undergoing Hemodialysis (HD). (ekstern lenke)
• Rannveig Skrunes; Kristin Kampevold Larsen; Sabine Maria Leh et al. (2015). FABRY DISEASE DIAGNOSED IN LIVING DONOR KIDNEY TRANSPLANT BIOPSY. (ekstern lenke)
• David Smerkous; Michael Mauer; Camilla Tøndel et al. (2023). Development of an online cloud-based tool for automatic measurement of foot process width (FPW) using deep learning (DL): Applications in assessment of podocyte injury in Fabry disease (FD). (ekstern lenke)
• Behzad Najafian; Kathleen Nicholls; Michael L West et al. (2023). The spectrum of podocyte injury in later onset (LO) variants of Fabry disease (FD). (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2019). Accumulation of Globotriaosylceramide in Podocytes (PC) in Fabry Nephropathy Is Associated with Progressive PC Loss. (ekstern lenke)
• Camilla Tøndel; Kristin M. Aakre; Atle Brun et al. (2008). Formula GFR overestimates Renal Function in Children and Adult Males with Fabry Disease and Stage 1-2 CKD. (ekstern lenke)
• Camilla Tøndel; Bjørn Egil Vikse; Bjarne Magnus Iversen et al. (2008). Renal biopsies in children in Norway 1988-2005: clinical variables, complications and prognosis. (ekstern lenke)
• Fu-Pang Chang; Michael Mauer; Alexey Sokolovskiy et al. (2016). Differential response of glomerular parietal epithelial cells and podocytes to enzyme replacement therapy in Fabry nephropathy. (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2016). Podocyte Hypertrophy and Globotriaosylceramide (GL-3) Accumulation Are Strong Predictors of Podocyte Loss in Enzyme Replacement Therapy Naïve Male Patients with Fabry Disease. (ekstern lenke)
• C Tøndel; Leif Bostad; LM Lægreid et al. (2005). Glomerular and vascular changes are prominent in renal biopsies in children and adolescents with Fabry disease and microalbuminuria. (ekstern lenke)
• Einar Svarstad; Rannveig Skrunes; Sabine Maria Leh et al. (2017). Simplified Clinical Pre-histologic Scoring Method of Kidney Biopsies in Fabry Disease. (ekstern lenke)
• Eli Eikefjord; Erling Andersen; Jan Anker Monssen et al. (2014). Quantification of glomerular filtration rate (GFR) using a modelbased MR renography technique provides good agreement with IohexolGFR and eGFR in 20 healthy subjects.. (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2017). Podocyte globotriaosylceramide (GL-3) content strongly impacts age-dependent podocyte loss in ERT-naïve male Fabry patients. (ekstern lenke)
• Behzad Najafian; Camilla Tøndel; Einar Svarstad et al. (2018). Podocyte structural parameters predict glomerular filtration rate (GFR) loss in male patients with classic Fabry disease. (ekstern lenke)
• Camilla Tøndel; Einar Svarstad; Leif Bostad (2009). Renal follow-up biopsies in young male Fabry patients on enzyme replacement therapy. (ekstern lenke)
• Einar Svarstad; O. Myking; Bjarne Magnus Iversen (2001). Substatntial loss of 1.25 (OH)2 D3 in the urine in patients with nephrotic syndrome. (ekstern lenke)
• Camilla Tøndel; Takahiro Kanai; Kristin Kampevold Larsen et al. (2014). Five Children with Fabry Disease and Significant Tissue Damage in Renal Biopsies Despite Normal Clinical Renal Parameters. (ekstern lenke)
• Linda van der Tol; L Vogt; S Florquin et al. (2014). Consensus recommendation on Fabry disease diagnosis in adult patients with kidney disease. (ekstern lenke)
• Camilla Tøndel; Cathrin Lytomt Salvador; Karl Ove Hufthammer et al. (2017). Single-point iohexol plasma clearance in children: validation of multiple formulas and sampling times. (ekstern lenke)
• Øyvind Kaarbøe; Leif Bostad; Bjarne Magnus Iversen et al. (2004). Early signs of focal and segmental glomerulosclerosis (FSGS) and arteriolopathy is prevalent in Fabry patients with minimal proteinuria or slightly reduced GFR. (ekstern lenke)
• Behzad Najafian; Aurelio Silvestroni; Alexey Sokolovskiy et al. (2022). Globotriaosylceramide (GL3) accumulation in Fabry podocytes in female patients is progressive with age and associated with podocyte loss and proteinuria. (ekstern lenke)
• Einar Svarstad; Rannveig Skrunes; Einar Skulstad Davidsen et al. (2019). Clinical Consequences of Paired Cardiac and Kidney Biopsies in a Treatment Naive Female Fabry Patient with a Classical Mutation and Minor Clnical Symptoms. (ekstern lenke)
• Camilla Tøndel; Bjørn Johan Bolann; Cathrin Lytomt Salvador et al. (2013). Glomerular filtration rate (GFR) measured by iohexolclearance in children; how many sample points are necessary?. (ekstern lenke)
• O. Myking; Einar Svarstad; Bjarne Magnus Iversen (2001). Vitamin D, tartrate-resistent acid phosphatase 5B and osteocalcin in bone metabolism in patients undergoing hemodialysis (HD). (ekstern lenke)
• Einar Svarstad; E. Sundal (2001). A simplified therapy regimen with epoetin alfa is sufficient in most HD-patients. (ekstern lenke)
• Behzad Najafian; Michael Mauer; Einar Svarstad et al. (2014). Enzyme Replacement Therapy (ERT) in Fabry Disease (FD) Reduces Podocyte (PC) Globotriaosylceramide (GL3) Content within a Year (yr). (ekstern lenke)
• Camilla Tøndel; Kristin Kampevold Larsen; Rannveig Skrunes et al. (2014). Renal Biopsies after 6-11 Years of Enzyme Replacement Therapy in 9 Young Classic Fabry Disease Patients. (ekstern lenke)
• Rannveig Skrunes; Kristin Kampevold Larsen; Einar Svarstad et al. (2014). Fabry nephropathy (FN) outcome and the impact of diagnostic kidney biopsies after 10 years enzyme replacement therapy (ERT). (ekstern lenke)
• Øystein Solberg Eikrem; Philipp Strauss; Miroslav Sekulic et al. (2018). Fabry nephropathy: Transcriptome sequencing of microdissected renal compartments from archival kidney biopsies at baseline, and after 5 & 10 years of enzyme replacement therapy. (ekstern lenke)
• Camilla Tøndel; Cathrin Lytomt Salvador; Karl Ove Hufthammer et al. (2018). IOHEXOL CLEARANCE IN CHILDREN WITH LOW GFR: COMPARISON OF 24 HOURS SINGLE-POINT GFR AND MULTIPLE-POINT GFR. (ekstern lenke)
• Thea Tislevoll Eide; Atle Brun; Damien Brackman et al. (2018). SINGLE INTRAVENOUS ACCESS FOR MEASUREMENT OF GLOMERULAR FILTRATION RATE IN CHILDREN AFTER MARKER INJECTION. (ekstern lenke)

Konferanseabstrakt

• Geir Mjøen; Gudrun Norby; Bjørn Egil Vikse et al. (2012). OUTCOME IN BIOPSY-PROVEN LUPUS NEPHRITIS. (ekstern lenke)
• Behzad Najafian; Chester Whitley; Beth Thurberg et al. (2013). Renal structural-functional relationship (SFR) studies suggest that podocyte GL-3 accumulation predicts urine protein creatinine ratio in Fabry disease (FD) nephropathy (FDN). (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2012). VALIDATION OF FRENCH MODEL TO PREDICT ESRD AND DEATH IN IGA NEPHROPATHY PATIENTS. (ekstern lenke)
• Agnes B Fogo; Leif Bostad; Einar Svarstad et al. (2010). SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN). (ekstern lenke)
• Behzad Najafian; Marie-Claire Gubler; Chester Whitley et al. (2010). Natural history and structural-functional relationships (SFR) in Fabry nephropathy (FN). (ekstern lenke)
• Einar Svarstad (2010). The Potential Importance of Renal Biopsies in Early Management Decisions in Young Fabry Patients. (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2012). STANDARDIZED MORTALITY RATE IN IGA NEPHROPATHY PATIENTS. (ekstern lenke)
• Behzad Najafian; Emily Glynn; Einar Svarstad et al. (2012). Mosaicism of Podocyte Involvement in Untreated Females with Fabry Disease. (ekstern lenke)
• Camilla Tøndel; Leif Bostad; Einar Svarstad (2010). RENAL FOLLOW-UP BIOPSIES IN YOUNG MALE FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY. (ekstern lenke)
• Camilla Tøndel; Anne Kjørsvik Bertelsen; Leif Bostad et al. (2009). Fabry Disease: Unusual Symptoms in two Boys Treated with Lamotrigine and Fabrazyme, Respectively. (ekstern lenke)
• Camilla Tøndel; Uma Ramaswami; Kristin Moberg Aakre et al. (2009). Monitoring renal Function in Fabry children; estimated or measured glomerular Filtration rate?. (ekstern lenke)
• Camilla Tøndel; Leif Bostad; Liv Marie Lægreid et al. (2008). Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria. (ekstern lenke)

Leserbrev

• Simon Körver; Ulla Feldt-Rasmussen; Einar Svarstad et al. (2019). Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data. (ekstern lenke)
• Yngvar Lunde Haaskjold; Aslaug Drotningsvik; Sabine Maria Leh et al. (2015). Renal Failure due to Excessive Intake of Almonds in the Absence of Oxalobacter formigenes. (ekstern lenke)
• Gunnar Houge; Camilla Tøndel; Øyvind Kaarbøe et al. (2011). Fabry or not Fabry – a question of ascertainment. (ekstern lenke)
• Einar Svarstad; Bjarne Magnus Iversen (2004). Renal artery thrombosis and acute renal failure after ACE inhibition. (ekstern lenke)
• Per Olav Rui; Einar Svarstad; Leif Bostad et al. (2012). En mann i 50-årene med feber, hoste og anuri. (ekstern lenke)
• Kristin Aakre; Thomas Helge Røraas; Per Hyltoft Petersen et al. (2013). Week-to-Week Biological Variation in the N-terminal Prohormone of Brain Natriuretic Peptide in Hemodialysis Patients and Healthy Individuals. (ekstern lenke)
• Heidrun Dahl Olstad; Einar Svarstad (2012). En kvinne i 50-årene med smerter i beina og nyresvikt. (ekstern lenke)
• Einar Svarstad; Dieter Hultstrøm; Dag Jensen et al. (2002). Renal artery thrombosis with acute renal failure after withdrawal of angiotensin converting enzyme inhibitor: a case report. (ekstern lenke)
• Yngvar Haaskjold; Aslaug Drotningsvik; Sabine Maria Leh et al. (2015). Renal failure due to excessive intake of almonds in the absence of Oxalobacter Formigenes.. (ekstern lenke)

Doktorgradsavhandling

• Einar Svarstad (2001). Renal hemodynamics in ambulatory patients with chronic renal disease. (ekstern lenke)

Lederartikkel

• Rolf E.F. Christiansen; Torunn Fiskerstrand; Sabine Leh et al. (2011). A Mother and Daughter with Unexplained Renal Failure. (ekstern lenke)

Vitenskapelig bokkapittel

• Svein Ødegaard; Geir Folvik; Einar Svarstad (2009). Ultralydveiledet biopsi og annen intervensjon. (ekstern lenke)
• Einar Svarstad (2009). Ultralyd av nyrer og urinveier. (ekstern lenke)

Medieintervju

• Camilla Tøndel; Einar Svarstad (2013). Enzyme replacement in Fabry disease. (ekstern lenke)

Rettelse i tidsskrift

• Camilla Tøndel; Bjørn Johan Bolann; Cathrin Lytomt Salvador et al. (2016). Erratum to: Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling times (Pediatric Nephrology, (2017), 32, 2, (311-320), 10.1007/s00467-016-3436-z). (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.